---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-126161"
form_type: "8-K"
ticker: "PHGE"
cik: "0001739174"
company_name: "BiomX Inc."
filed_at: "2025-12-29T23:59:59+00:00"
generated_at: "2026-05-16T12:07:07.871225+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# BiomX raises $3.0M in private placement of Series Y Preferred and warrants

## Summary
- Gross proceeds $3.0M from sale of 3,300 shares Series Y Convertible Preferred (stated value $1,000/share) and warrants for 3.3M common shares.
- Warrants exercisable at $2.00/share for 5 years; conversion price for preferred also initially $2.00.
- Series Y Preferred carries 15% annual dividend payable quarterly in cash or common stock, maturity 1 year.
- Investor gets board representation: one director if owns ≥9.99% of common; second director if ≥19.99% after stockholder approval.
- Stockholders' meeting required within 60 days to approve issuance of shares exceeding 19.99% of outstanding common.

## SEC filing metadata
- accession: 0001213900-25-126161
- form_type: 8-K
- ticker: PHGE
- cik: 0001739174
- company_name: BiomX Inc.
- filed_at: 2025-12-29T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1739174/000121390025126161/0001213900-25-126161-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1739174/000121390025126161/ea0271117-8k_biomx.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-126161
- JSON: https://secwatch.observer/filing/0001213900-25-126161.json
- Plain text: https://secwatch.observer/filing/0001213900-25-126161.txt

## Source-grounded claims
- claim_id: 2b3c97851506f2d17b1bb01ad2b8659a4af37b1e
  claim: BiomX Inc. entered into Securities Purchase Agreement with an investor valued at $3.0 million (effective 2025-12-26).
  evidence_excerpt: On December 26, 2025, BiomX Inc., Inc., a Delaware corporation (the “Company” or “BiomX”), entered into a Securities Purchase Agreement (the “Securities Purchase Agreement”) with an investor (the “Investor”), pursuant to which the Company agreed to issue and sell, in a private placement transaction, an aggregate of 3,300 shares of the Company’s newly created Series Y Convertible Preferred Stock, par value $0.0001 per share (the “Series Y Preferred Stock”), with an aggregate stated value of $3.3 million, and warrants to purchase shares of the Company’s common stock, par value $0.0001 per share (the “Common Stock”), for expected aggregate gross proceeds to the Company of $3.0 million, before deducting placement agent fees and other offering expenses.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1739174/000121390025126161/0001213900-25-126161-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.